THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Nuveen, LLC's Holding History (CIK: 0001871926)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 88,988 Value ($000) $1,665 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 92,214 Value ($000) $1,346 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 120,588 Value ($000) $1,330 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 374,952 Value ($000) $3,348 Avg Close $9.31 Range $8.35 - $10.90

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	88,988	$1,665	$16.59	$13.50 - $20.33
Q3 2025	92,214	$1,346	$12.64	$10.82 - $14.87
Q2 2025	120,588	$1,330	$9.72	$7.90 - $11.82
Q1 2025	374,952	$3,348	$9.31	$8.35 - $10.90